Showing results (271-280 of 556) with videos related to
Sort By:
Pageof 56
American Journal of Nuclear Medicine and Molecular Imaging|January 13, 2017
Absorbed radiation dosimetry of the D3-specific PET radioligand [18F]FluorTriopride estimated using rodent and nonhuman primateRichard Laforest, Morvarid Karimi, Stephen M Moerlein, et al.Annals of Clinical and Translational Neurology|July 26, 2021
Distinct progression patterns across Parkinson disease clinical subtypesPeter S Myers, Joshua J Jackson, Amber K Clover, et al.Cerebral Cortex (New York, N.Y. : 1991)|June 8, 2018
Emergent Functional Network Effects in Parkinson DiseaseCaterina Gratton, Jonathan M Koller, William Shannon, et al.Archives of Neurology|March 14, 2012
Reduced uptake of FDOPA PET in end-stage liver disease with elevated manganese levelsSusan R Criswell, Joel S Perlmutter, Jeffrey S Crippin, et al.Annals of Neurology|August 5, 2004
Novel haplotypes in 17q21 are associated with progressive supranuclear palsyPau Pastor, Mario Ezquerra, J Christian Perez, et al.Brain : a Journal of Neurology|September 22, 2010
Mapping Go-No-Go performance within the subthalamic nucleus regionTamara Hershey, Meghan C Campbell, Tom O Videen, et al.Parkinsonism & Related Disorders|January 30, 2015
Secured web-based video repository for multicenter studiesLing Yan, Matt Hicks, Korey Winslow, et al.Nuclear Medicine and Biology|January 3, 2026
PET evaluation of cholinergic system differences in progressive supranuclear palsy and age-matched controls using [18F]VATYing-Hwey Nai, John L O'Donnell, Aaron Tanenbaum, et al.Royal Society Open Science|August 16, 2018
Mapping movement, mood, motivation and mentation in the subthalamic nucleusAmritha Gourisankar, Sarah A Eisenstein, Nicholas T Trapp, et al.Journal of Neurology|January 27, 2021
Blood-brain barrier permeability in Parkinson's disease patients with and without dyskinesiaKoji Fujita, Shichun Peng, Yilong Ma, et al.Pageof 56